Response of malignant thymoma to erlotinib

Annals of Oncology

Volumn 19, Issue 7, 2008, Pages 1361-1362

  Christodoulou, C ^a,b   Murray, S ^a   Dahabreh, J ^c   Petraki, K ^a   Nikolakopoulou, A ^a   Mavri, A ^b,c   Skarlos, D ^a  

^a METROPOLITAN HOSPITAL   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c ATHENS MEDICAL CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; PYRIDOSTIGMINE;

ADULT; ADVANCED CANCER; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG ERUPTION; DRUG RESPONSE; FEMALE; GENE AMPLIFICATION; GENERAL CONDITION DETERIORATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MALIGNANT NEOPLASTIC DISEASE; MIXED TUMOR; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; MYASTHENIA; PRIORITY JOURNAL; RELAPSE; RESPIRATORY FAILURE; THYMOMA;

ADULT; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; EPIDERMAL GROWTH FACTOR; FATAL OUTCOME; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEIN KINASE INHIBITORS; QUINAZOLINES; THYMOMA;

EID: 46249091420     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn388     Document Type: Letter

References (4)

1. Henley JD, Koukoulis GK, Loehrer PJ Sr. Epidermal growth factor receptor expression in invasive thymoma. J Cancer Res Clin Oncol 2002; 128: 167-170.
2. Meister M, Schirmacher P, Dienemann H et al. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Cancer Lett. 2007; 248: 186-191.
3. Kurup A, Burns M, Dropcho S et al. Phase II study of gefitinib treatment in advanced thymic malignancies. J Clin Oncol 2005; 23(Pt 1): (Abstr 7068).
4. Farina G, Garassino MC, Gambacorta M et al. Response of thymoma to cetuximab. Lancet Oncol 2007; 8: 449-450.